Free Weekly Vaccines Industry Newsletter Get the latest news about Research Breakthroughs, R&D Trends, Clinical Trials, and Vaccine Production sent straight to your Inbox. Join over 25,000 lab research professionals who subscribe to FierceVaccines for FREE!
Massachusetts-based biotech Visterra is preparing to move its universal influenza therapy into the clinic. Visterra is talking up the engineered antibody as way to both prevent and treat seasonal and pandemic flu infections. News
Proactive Planning: How Supply Chain Risk Mapping Can Prevent Costly Disruptions
| Wednesday, July 22nd | 11am ET / 8am PT | Sponsored by: UPS
Biopharma companies can never eliminate the risk of supply chain disruption, but they can prevent some problems and prepare themselves for others. Knowing every company in the supply chain--from tier one down--and having contingency plans in place are essential steps to foreseeing and responding to disruptions. Maps of supply chain risks give companies this knowledge. Register Now!
FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Click here to get your free weekly email briefing today!